HRP20050867A2 - Pharmaceutical compositions having reduced bitter taste - Google Patents

Pharmaceutical compositions having reduced bitter taste

Info

Publication number
HRP20050867A2
HRP20050867A2 HR20050867A HRP20050867A HRP20050867A2 HR P20050867 A2 HRP20050867 A2 HR P20050867A2 HR 20050867 A HR20050867 A HR 20050867A HR P20050867 A HRP20050867 A HR P20050867A HR P20050867 A2 HRP20050867 A2 HR P20050867A2
Authority
HR
Croatia
Prior art keywords
pharmaceutical compositions
bitter taste
reduced bitter
reduced
taste
Prior art date
Application number
HR20050867A
Inventor
Harshal Shiravadekar S.
Original Assignee
Pliva - Istraživanje i razvoj d.o.o.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva - Istraživanje i razvoj d.o.o. filed Critical Pliva - Istraživanje i razvoj d.o.o.
Publication of HRP20050867A2 publication Critical patent/HRP20050867A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
HR20050867A 2003-04-02 2005-09-30 Pharmaceutical compositions having reduced bitter taste HRP20050867A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/HR2003/000013 WO2004087096A1 (en) 2003-04-02 2003-04-02 Pharmaceutical compositions having reduced bitter taste

Publications (1)

Publication Number Publication Date
HRP20050867A2 true HRP20050867A2 (en) 2005-12-31

Family

ID=33104888

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20050867A HRP20050867A2 (en) 2003-04-02 2005-09-30 Pharmaceutical compositions having reduced bitter taste

Country Status (8)

Country Link
EP (1) EP1608333A1 (en)
JP (1) JP2006514968A (en)
CN (1) CN1744881A (en)
AU (1) AU2003214486A1 (en)
CA (1) CA2521253A1 (en)
EA (1) EA200501552A1 (en)
HR (1) HRP20050867A2 (en)
WO (1) WO2004087096A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1889932A (en) 2003-12-04 2007-01-03 辉瑞产品公司 Method of making pharmaceutical multiparticulates
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
JP4963846B2 (en) * 2006-03-03 2012-06-27 エルメッド エーザイ株式会社 Orally disintegrating tablet and method for producing the same
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
PE20130638A1 (en) 2010-04-15 2013-07-01 Chromocell Corp COMPOUNDS, COMPOSITIONS AND METHODS TO REDUCE OR ELIMINATE THE BITTER FLAVOR
TWI564008B (en) * 2010-09-30 2017-01-01 鹽野義製藥股份有限公司 Formulation for solubility enhancement of poorly soluble drugs
ES2841809T3 (en) 2011-06-03 2021-07-09 Eisai R&D Man Co Ltd Biomarkers to predict and evaluate the degree of response of subjects with thyroid and kidney cancer to lenvatinib compounds
MY167212A (en) * 2011-10-20 2018-08-14 Chromocell Corp Compounds, composition, and methods for reducing or eliminating bitter taste
CN102824311A (en) * 2012-09-11 2012-12-19 广西禾力药业有限公司 Azithromycin granules capable of covering up bitter
EP2801349A1 (en) 2013-05-06 2014-11-12 Siegfried AG Oral Pharmaceutical Formulation
HRP20221047T1 (en) 2014-08-28 2022-11-11 Eisai R&D Management Co., Ltd. High-purity quinoline derivative and method for manufacturing same
FI3263106T3 (en) 2015-02-25 2024-01-03 Eisai R&D Man Co Ltd Method for suppressing bitterness of quinoline derivative
CA2978226A1 (en) 2015-03-04 2016-09-09 Merck Sharpe & Dohme Corp. Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
CA2988707C (en) 2015-06-16 2023-10-10 Eisai R&D Management Co., Ltd. Combination of cbp/catenin inhibitor and immune checkpoint inhibitor for treating cancer
US20180228832A1 (en) * 2015-08-18 2018-08-16 Pharma Seeds Create, Llc Stomatological composition containing nsaid or heparin compound
CN105534940B (en) * 2016-02-19 2018-12-07 国药集团致君（深圳）坪山制药有限公司 A kind of diclofenac sodium extended action tablet composition and preparation method thereof
CN112438979B (en) * 2019-09-04 2022-05-27 普济生物科技（台州）有限公司 Vortioxetine hydrobromide-containing coated particles, solid dispersions and formulations for oral taste masking
CN112076168A (en) * 2020-09-24 2020-12-15 丽珠集团丽珠制药厂 Roxithromycin dispersible tablet and preparation method thereof
CN112641718B (en) * 2020-12-25 2022-07-29 山东大学 Taste-masking compound based on porous carrier and preparation method and application thereof
CN113181133A (en) * 2021-04-25 2021-07-30 海南通用三洋药业有限公司 Preparation method of roxithromycin capsules
CN116420874A (en) * 2023-04-26 2023-07-14 仙乐健康科技股份有限公司 A composition without bitter taste and product comprising the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
TW271400B (en) * 1992-07-30 1996-03-01 Pfizer
US6475510B1 (en) * 1997-12-19 2002-11-05 Smithkline Beecham Corporation Process for manufacturing bite-dispersion tablets
RU2270695C2 (en) * 1999-03-17 2006-02-27 Дайити Фармасьютикал Ко., Лтд. Pharmaceutical composition

Also Published As

Publication number Publication date
EA200501552A1 (en) 2006-04-28
CA2521253A1 (en) 2004-10-14
AU2003214486A1 (en) 2004-10-25
EP1608333A1 (en) 2005-12-28
CN1744881A (en) 2006-03-08
WO2004087096A1 (en) 2004-10-14
JP2006514968A (en) 2006-05-18

Similar Documents

Publication Publication Date Title
HRP20050867A2 (en) Pharmaceutical compositions having reduced bitter taste
GB0320382D0 (en) Pharmaceutical compositions
GB0327723D0 (en) Pharmaceutical compositions
GB2389530B (en) Pharmaceutical compositions
PL1633391T3 (en) Stabilized pharmaceutical peptide compositions
IL175973A0 (en) Pharmaceutical compositions comprising lercanidipine
IL172824A0 (en) Pharmaceutical formulations
GB0302671D0 (en) Pharmaceutical formulations
ZA200605080B (en) Pharmaceutical compositions
IL170313A (en) Diarylcycloalkyl derivatives and pharmaceutical compositions comprising them
GB2391473B (en) Pharmaceutical compositions
GB0300427D0 (en) Pharmaceutical composition
GB0300531D0 (en) Pharmaceutical compositions
HK1084670A1 (en) Pharmaceutical compositions comprising cabbinochreme type compounds
EP1648411A4 (en) Pharmaceutical compositions
AU2003221699A8 (en) Pharmaceutical preparation for taste masking
EP1699458A4 (en) Pharmaceutical composition
GB0302672D0 (en) Pharmaceutical formulations
HU0302441D0 (en) Pharmaceutical compositions having antibiothic effect
GB0316341D0 (en) Pharmaceutical formulations
GB0213481D0 (en) Pharmaceutical compositions
GB0300885D0 (en) Pharmaceutical composition
EP1585530A4 (en) Bioadhesive pharmaceutical compositions
GB0306933D0 (en) Pharmaceutical composition
GB0305579D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20060404

Year of fee payment: 4

OBST Application withdrawn